iBio, Inc. is a pioneering biotechnology firm specializing in plant-based biopharmaceutical production, headquartered in New York. The company offers contract development and manufacturing services for biologics, focusing on vaccines and therapeutics, thereby serving as a vital partner for organizations in the United States and internationally. With its proprietary technologies, iBio is dedicated to improving efficiency and scalability in the biologics manufacturing process, addressing the increasing demand for sustainable and cost-effective solutions in the rapidly evolving life sciences sector.
Click "Analyze" to generate stock analysis
IBIO Price Trend and Signals
IBIO Financials
2025-10-30Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-29Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-28Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-22Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-22Bullishprice_signal
Large price change detected: 25.23%.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-21Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-21Bullishprice_signal
Large price change detected: 24.72%.
2025-10-20Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.